CA Stock MarketDetailed Quotes

Optimind Pharma Corp (OMND)

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayMarket Closed Aug 19 13:59 ET
515.74KMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Optimind Pharma Corp (OMND) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Aug 31, 2025
(Q1)May 31, 2025
(FY)Feb 28, 2025
(Q4)Feb 28, 2025
(Q3)Nov 30, 2024
(Q2)Aug 31, 2024
(Q1)May 31, 2024
(FY)Feb 29, 2024
(Q4)Feb 29, 2024
(Q3)Nov 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
103.32%10.81K
-80.82%22.52K
54.30%-214.92K
-492.28%-18.81K
266.20%12.17K
-50.87%-325.69K
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
Net income from continuing operations
86.88%-10.84K
99.70%-294
84.56%-215.81K
96.22%-26.7K
91.34%-9.04K
55.01%-82.56K
75.85%-97.5K
54.60%-1.4M
64.41%-706.01K
67.02%-104.42K
Depreciation and amortization
----
----
--0
--0
--0
--0
--0
-54.39%19.95K
--0
-54.39%4.99K
Asset impairment expenditure
----
----
--0
----
----
----
----
-68.93%564.61K
----
----
Remuneration paid in stock
----
----
--0
--0
--0
--0
--0
--162.4K
--0
--0
Deferred tax
----
----
--0
----
----
----
----
1.02%-8.76K
----
----
Other non cashItems
--0
--800
----
----
----
----
----
-73.27%83.86K
-94.05%16.92K
-38.20%8.9K
Change In working capital
108.90%21.64K
-89.76%22.01K
-99.15%890
-93.93%7.9K
-74.51%21.21K
-253.23%-243.13K
648.34%214.91K
181.96%105.25K
770.55%130.07K
584.21%83.21K
-Change in receivables
193.96%25.7K
-95.39%4.98K
312.13%93.13K
-5.40%-6.03K
145.50%18.43K
-16.85%-27.35K
585.07%108.08K
57.88%-43.9K
92.20%-5.72K
132.37%7.51K
-Change in payables and accrued expense
98.12%-4.06K
-84.06%17.03K
-161.84%-92.24K
-89.74%13.93K
-96.32%2.79K
-375.05%-215.78K
731.71%106.83K
716.95%149.15K
152.05%135.78K
1,161.70%75.7K
Cash from discontinued investing activities
Operating cash flow
103.32%10.81K
-80.82%22.52K
54.30%-214.92K
-492.28%-18.81K
266.20%12.17K
-50.87%-325.69K
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
89.63%-22.86K
99.67%-212
55.44%-15.6K
Net business purchase and sale
----
----
----
----
--0
--0
--0
--0
-78.54%22.65K
55.44%-15.6K
Net other investing changes
----
----
----
----
----
----
----
86.59%-22.86K
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--0
--0
--0
--0
--0
89.63%-22.86K
99.67%-212
55.44%-15.6K
Financing cash flow
Cash flow from continuing financing activities
988.16%270K
0
0
4.41%270K
0
32.53%-30.4K
0
-2,335.09%-277.6K
Net issuance payments of debt
----
----
--0
--0
--0
--0
--0
32.53%-30.4K
--0
33.33%-7.6K
Net common stock issuance
----
----
--270K
--0
--0
----
----
--0
--0
---270K
Cash from discontinued financing activities
Financing cash flow
----
----
988.16%270K
--0
--0
2,468.42%270K
--0
32.53%-30.4K
--0
33.33%-7.6K
Net cash flow
Beginning cash position
-27.25%106.29K
191.94%83.77K
-94.80%28.7K
219.73%102.58K
44.42%90.41K
-50.12%146.1K
-94.80%28.7K
-70.29%552.22K
-95.93%32.08K
-94.52%62.6K
Current changes in cash
119.40%10.81K
-80.82%22.52K
110.52%55.08K
-455.21%-18.81K
139.87%12.17K
75.82%-55.69K
145.28%117.41K
59.93%-523.52K
98.56%-3.39K
91.40%-30.52K
End cash Position
29.51%117.09K
-27.25%106.29K
191.94%83.77K
191.94%83.77K
219.73%102.58K
44.42%90.41K
-50.12%146.1K
-94.80%28.7K
-94.80%28.7K
-95.93%32.08K
Free cash from
103.32%10.81K
-80.82%22.52K
54.30%-214.92K
-492.28%-18.81K
266.20%12.17K
-50.87%-325.69K
148.14%117.41K
54.82%-470.27K
98.00%-3.18K
97.63%-7.32K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Aug 31, 2025(Q1)May 31, 2025(FY)Feb 28, 2025(Q4)Feb 28, 2025(Q3)Nov 30, 2024(Q2)Aug 31, 2024(Q1)May 31, 2024(FY)Feb 29, 2024(Q4)Feb 29, 2024(Q3)Nov 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 103.32%10.81K-80.82%22.52K54.30%-214.92K-492.28%-18.81K266.20%12.17K-50.87%-325.69K148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K
Net income from continuing operations 86.88%-10.84K99.70%-29484.56%-215.81K96.22%-26.7K91.34%-9.04K55.01%-82.56K75.85%-97.5K54.60%-1.4M64.41%-706.01K67.02%-104.42K
Depreciation and amortization ----------0--0--0--0--0-54.39%19.95K--0-54.39%4.99K
Asset impairment expenditure ----------0-----------------68.93%564.61K--------
Remuneration paid in stock ----------0--0--0--0--0--162.4K--0--0
Deferred tax ----------0----------------1.02%-8.76K--------
Other non cashItems --0--800---------------------73.27%83.86K-94.05%16.92K-38.20%8.9K
Change In working capital 108.90%21.64K-89.76%22.01K-99.15%890-93.93%7.9K-74.51%21.21K-253.23%-243.13K648.34%214.91K181.96%105.25K770.55%130.07K584.21%83.21K
-Change in receivables 193.96%25.7K-95.39%4.98K312.13%93.13K-5.40%-6.03K145.50%18.43K-16.85%-27.35K585.07%108.08K57.88%-43.9K92.20%-5.72K132.37%7.51K
-Change in payables and accrued expense 98.12%-4.06K-84.06%17.03K-161.84%-92.24K-89.74%13.93K-96.32%2.79K-375.05%-215.78K731.71%106.83K716.95%149.15K152.05%135.78K1,161.70%75.7K
Cash from discontinued investing activities
Operating cash flow 103.32%10.81K-80.82%22.52K54.30%-214.92K-492.28%-18.81K266.20%12.17K-50.87%-325.69K148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K
Investing cash flow
Cash flow from continuing investing activities 0000089.63%-22.86K99.67%-21255.44%-15.6K
Net business purchase and sale ------------------0--0--0--0-78.54%22.65K55.44%-15.6K
Net other investing changes ----------------------------86.59%-22.86K--------
Cash from discontinued investing activities
Investing cash flow ----------0--0--0--0--089.63%-22.86K99.67%-21255.44%-15.6K
Financing cash flow
Cash flow from continuing financing activities 988.16%270K004.41%270K032.53%-30.4K0-2,335.09%-277.6K
Net issuance payments of debt ----------0--0--0--0--032.53%-30.4K--033.33%-7.6K
Net common stock issuance ----------270K--0--0----------0--0---270K
Cash from discontinued financing activities
Financing cash flow --------988.16%270K--0--02,468.42%270K--032.53%-30.4K--033.33%-7.6K
Net cash flow
Beginning cash position -27.25%106.29K191.94%83.77K-94.80%28.7K219.73%102.58K44.42%90.41K-50.12%146.1K-94.80%28.7K-70.29%552.22K-95.93%32.08K-94.52%62.6K
Current changes in cash 119.40%10.81K-80.82%22.52K110.52%55.08K-455.21%-18.81K139.87%12.17K75.82%-55.69K145.28%117.41K59.93%-523.52K98.56%-3.39K91.40%-30.52K
End cash Position 29.51%117.09K-27.25%106.29K191.94%83.77K191.94%83.77K219.73%102.58K44.42%90.41K-50.12%146.1K-94.80%28.7K-94.80%28.7K-95.93%32.08K
Free cash from 103.32%10.81K-80.82%22.52K54.30%-214.92K-492.28%-18.81K266.20%12.17K-50.87%-325.69K148.14%117.41K54.82%-470.27K98.00%-3.18K97.63%-7.32K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +16.12%
Sample Name
Sample Code
 +15.49%
Sample Name
Sample Code
 +12.97%
4
BIDU-SW
09888
+5.31%
5
JD HEALTH
06618
+4.46%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -